Skip to main content

Research Alliance Corp III

RACC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002118032

No open-market purchases or sales by Research Alliance Corp III insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $79.6M in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +23 vs. previous quarter
23
13F valueReported value at the end of Q2 2026
$79.6M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding RACC, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding RACC at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Research Alliance Corp III insiders from Form 4, newest first.

See all insider trades

No open-market purchases or sales by Research Alliance Corp III insiders are on file.

Top 10 13F holders, Q2 2026

The largest institutional positions in Research Alliance Corp III at the end of Q2 2026; share changes are against Q1 2026.

See all 23 holders
Institutions holding RACC in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Perceptive Advisors LLC750,000$8.03M0.12%+750,000New
ADAR1 Capital Management, LLC650,000$6.96M0.33%+650,000New
BVF Inc500,000$5.35M0.14%+500,000New
Balyasny Asset Management LLC500,000$5.35M0.01%+500,000New
Commodore Capital LP500,000$5.35M0.32%+500,000New
TCG Crossover Management, LLC500,000$5.35M0.13%+500,000New
Spruce Street Capital LP500,000$5.35M1.05%+500,000New
Trails Edge Capital Partners, LP500,000$5.35M0.85%+500,000New
Jupiter Topco LLC400,000$4.37M0.00%+400,000New
Braidwell LP400,000$4.28M0.16%+400,000New